• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS, INC. LEAD MODEL 304

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS, INC. LEAD MODEL 304 Back to Search Results
Model Number 304-20
Device Problems Migration or Expulsion of Device (1395); Material Protrusion/Extrusion (2979)
Patient Problems Pain (1994); Injury (2348)
Event Date 08/01/2012
Event Type  Injury  
Event Description
Clinic notes dated (b)(6) 2013 note that the patient has lumps along the vagal nerve stimulator.The notes indicate that the lumps are the tie downs that secure the strain relief.It was noted that the patient's mother indicated that since the patient was hit in the neck with a ball that the tie downs have been more prominent.The mother indicated that the patient's previous physician performed diagnostics after the patient was hit in the neck with the ball and that diagnostics were within normal limits.The notes indicate that the patient will be referred for surgery to have the tie downs removed to prevent possible erosion through the patient's skin resulting in an infection.The notes indicate that the tie downs are painful to the touch and are nearly at the point of breaking through the skin.The notes indicate that the tie downs have definitely migrated and are protruding out through the skin.The patient was scheduled for surgical revision of the tie downs.
 
Event Description
On (b)(6) 2014 it was confirmed that the patient underwent surgery on (b)(6) 2013 to remove the two lead tie-downs.Per the op-notes received, the pre-op diagnosis was that the two tie-down tabs were protruding into the skin with thinning of the skin over the tie-down tabs and concern for skin erosion.It was noted that the patient was hit in the neck by a ball recently and when this happened, these tie-down tabs became more prominent.The surgeon stated that the patient has very thin skin and the tie-down tabs were protruding through the neck and can be seen under the skin to the point where you can almost see the fact that they were white.There was no evidence of skin breakdown or infection during surgery.Diagnostics were performed before and after the removal of the tie-downs confirming lead impedance within normal limits.During removal of one of the tie-downs, scar tissue was removed as well from around the tie-down.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 304
Type of Device
LEAD
Manufacturer (Section D)
CYBERONICS, INC.
100 cyberonics blvd
houston TX 77058 770
Manufacturer (Section G)
CYBERONICS, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key3632097
MDR Text Key4178372
Report Number1644487-2014-00445
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/17/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/19/2014
Device Model Number304-20
Device Lot Number2815
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Date Manufacturer Received09/25/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/20/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age4 YR
-
-